Pulmonary Cell News Volume 15.15 | Aug 13 2026

    0
    18






    2026-08-13 | PULCN 15.15


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 15.15 – 13 August, 2026
    TOP STORY

    Biomarkers of Nivolumab Benefit in Resectable Non-Small Cell Lung Cancer

    Researchers identified circulating tumor DNA clearance and molecular residual disease as key biomarkers of nivolumab benefit and recurrence risk in resectable non-small cell lung cancer.
    [Nature]

    Full Article
    Tips to help you decide whether to pursue a postdoctoral position.
    PUBLICATIONSListed by the impact factor of the journal

    BCL9 Inhibition Promotes Fibroblast Lipogenesis by Regulating Macrophage-Fibroblast Interactions to Attenuate Pulmonary Fibrosis

    Scientists identified B cell lymphoma 9 (BCL9) as a key upstream regulator implicated in idiopathic pulmonary fibrosis pathogenesis. They demonstrated that BCL9 drives the macrophage M2 program through the MerTK-ERK-SPP1 axis.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Pulmonary Delivery of Self-Amplifying RNA: Balancing Inflammation and Durable Transgene Expression

    The authors demonstrated that intratracheal administration of self-amplifying mRNA-lipid nanoparticles can cause significant side effects that can be linked to innate immune cell recruitment and cytokine release in the lungs.
    [ACS Nano]

    Full Article
    |
    Graphical Abstract

    Amiloride Mitigates Respiratory Distress Caused by WFDC2 Deficiency via Inhibiting the Epithelial Sodium Channel

    Investigators explored the p.C97W variant in WAP four-disulfide core domain protein 2 (WFDC2), proposed as a new genetic origin of respiratory distress.
    [Nature Communications]

    Abstract

    MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non-Small Cell Lung Cancer

    Scientists found that Mpr1/Pad1 N-terminal domain-containing protein (MPND) is frequently deleted, and its expression is significantly downregulated in NSCLC tumor tissues.
    [Cancer Research]

    Full Article

    Hypoxia-Induced MIC19 Myristoylation Promotes PRKN-Dependent VDAC2 Ubiquitination and Activates Mitophagy in Non-Small Cell Lung Cancer

    Researchers identified MIC19, a key subunit of mitochondrial contact site and cristae organizing system complex, as an essential regulator of hypoxia-induced mitophagy in NSCLC.
    [Oncogene]

    Abstract | Graphical Abstract

    VHH-Based CAR-T Cells Targeting DLL3 Show High Efficacy in Small Cell Lung Cancer Models

    Investigators showed that DLL3-targeting variable domain of heavy-chain–only antibodies (VHH)-based chimeric antigen receptor T (CAR-T) cells exhibit potent antitumor activity against small cell lung cancer, supporting their potential as a new immunotherapy for DLL3-positive tumors.
    [Molecular Cancer Therapeutics]

    Abstract
    Two scientists in lab coats talking to each other in a life science laboratory.
    REVIEWS

    Fucosyltransferases in Asthma: Regulators of Epithelial Dysfunction, Senescence, and Airway Inflammation

    Scientists summarize the current knowledge of the fucosyltransferase family and critically evaluate the evidence linking aberrant fucosylation to asthma pathogenesis.
    [Clinical Reviews in Allergy & Immunology]

    Abstract
    INDUSTRY AND POLICY NEWS

    UCLA Researchers Receive $1.2 Million to Study Diabetes Drug As a Potential Treatment for Early-Stage Lung Cancer

    UCLA researchers received a $1.2 million grant to investigate whether a common diabetes drug could slow early-stage lung adenocarcinoma and help prevent future lung cancers.
    [UCLA Health]

    Press Release

    UToledo Research Receives Funding from Stand Up To Cancer to Test Early Warning for Lung Cancer

    Dr. James Willey, a pulmonary physician at University of Toledo (UToledo) Health and holder of the George Isaac Chair In Cancer Research, has received a $200,000 Stand Up To Cancer grant to support a simple, noninvasive screening test for lung cancer.
    [University of Toledo]

    Press Release
    FEATURED EVENT

    ESMO Congress 2026

    October 23-27, 2026
    Madrid, Spain

    > See All Events

    JOB OPPORTUNITIES

    Faculty Positions – Cancer Research

    Thomas Jefferson University – Philadelphia, Pennsylvania, United States

    Postdoctoral Fellow – Computational Biology

    University of British Columbia – Vancouver, British Columbia, Canada

    Assistant Professor – Developmental and Stem Cell Biology

    Cedars Sinai Medical Center – Los Angeles, California, United States

    Postdoctoral Fellow – Immunology

    Boston University – Boston, Massachusetts, United States

    Postdoctoral Program – Integrated Science Lab

    UmeÃ¥ University – UmeÃ¥, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2